Future Market Insights.png
Mammalian Cell Fermentation Technology Market anticipated journey towards the lucrative US$ 68 Billion valuation. At a CAGR of 10% by 2034 | Future Market Insights, Inc. NEWARK, Del, April 23, 2024 (GLOBE NEWSWIRE) -- The mammalian cell fermentation technology market is estimated to be worth US$ 45.9 billion in 2024 and is projected to be valued at US$ 68 billion by...
Conagen collaborates with MIT and DARPA on ReSource Program
Conagen's Fermentation Technology To Support DARPA's ReSource Sustainability Program
December 08, 2021 04:34 ET | Conagen
Bedford, Mass., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Massachusetts-based biotech Conagen announced its participation in a collaboration supporting the ReSource program funded by a U.S. Department of...
Cytovance_HepaLink_Digtial_032017.jpg
Cytovance Biologics to Participate in RAFT Scientific Discussion on Commercialization of Fermentation Processes
October 18, 2019 17:24 ET | Cytovance Biologics
OKLAHOMA CITY, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate...